Oral Squamous Cell Carcinoma (OSCC) Active Not Recruiting Phase 2 Trials for Docetaxel (DB01248)

Back to Oral Squamous Cell Carcinoma (OSCC)

Also known as: Squamous Cell Carcinoma of the Oral Cavity / Oral Cavity Squamous Cell Carcinoma / Squamous Cell Cancer of the Oral Cavity / Squamous Cell Carcinoma (SCC) of the Oral Cavity / Oral Squamous Cell Carcinoma / Squamous Cell Carcinoma Mouth / Squamous Cell Carcinoma (SCC) of the Mouth / Squamous Cell Carcinoma of Mouth / Squamous Cell Carcinoma of the Oral / Squamous cell carcinoma of mouth (disorder)

IndicationStatusPhase
DBCOND0087451 (Oral Squamous Cell Carcinoma (OSCC))Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04649476Neoadjuvant PD-1 Blockade in Resectable Oral Squamous Cell CarcinomaTreatment